The quiet creep of antibiotic resistance is an increasing danger to public health. Over the last several decades, the protection against deadly infections has become limited, and in some cases, non-existent with eight known pathogens resistant to available antibiotics. Aided by the inappropriate use of antibiotics, these so-called superbugs, once considered rare, are becoming common in healthcare facilities throughout the United States. To bring awareness to this health emergency, the Society for Healthcare Epidemiology of America (SHEA) is partnering with the Centers for Disease Control and Prevention (CDC) and others for Get Smart about Antibiotics Week.
Over time our arsenal against infections has dwindled, but we continue to assume another, stronger antibiotic will be available to take its place. With little investment in new antibiotics, we must work to reevaluate how we use antibiotics we have available to prolong the efficacy of these medications, says Sara Cosgrove, MD, MS, associate professor of medicine at Johns Hopkins University School of Medicine and a SHEA board member.
Drug-resistant bugs are associated with increased patient morbidity, mortality and higher healthcare costs spent on futile use of antibiotics and longer, more intensive hospital stays. One tool to combat the rise of antibiotic-resistant bacteria is antimicrobial stewardship programs and interventions. Antimicrobial stewardship helps prescribers know when antibiotics are needed and what the best treatment choices are for a particular patient to help improve the use of these drugs. The goal is to ensure patients receive antibiotics only when needed and in the safest way possible.
Recent studies published in the journal Infection Control and Hospital Epidemiology demonstrate the need for stewardship programs to provide safe, high quality and cost-effective care:
 Antibiotic use can put patients at risk of serious infections. Up to 85 percent of patients with potentially fatal Clostridium difficile-associated diseases have been exposed to antibiotics in the preceding 28 days.
 In a study in 128 veterans hospitals, switching from IV to oral antibiotics was found to be safe, to potentially reduce costs and to increase hospital staff awareness of appropriate antibiotic use. Antibiotics administered by IV are known to hinder patients through longer hospital stays.
 Restricting ciprofloxacin in hospital units has been linked to a decrease in multi-drug resistant bacteria.
 By closely monitoring antibiotic use, an antimicrobial stewardship program at a university medical center cut costs for antimicrobials nearly $3 million. After the program was ended, costs increased again by $2 million in two years.
Visit the SHEA website for more information on the appropriate use and management of antimicrobials in all healthcare settings to help slow resistance and improve patient care. Among the resources available are a comprehensive resource page and an online training for health professionals.
Â
Â
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.